JSM 2014 Home
Online Program Home
My Program

Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.

Activity Details

377 * ! Tue, 8/5/2014, 2:00 PM - 3:50 PM CC-252B
Optimizing Drug Development Programs and Portfolios: Beyond Adaptive Design — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): James A. Bolognese, Cytel
Chair(s): James A. Bolognese, Cytel   
2:05 PM Early Clinical Development Planning via Biomarkers, Clinical Endpoints, and Simulation: A Case Study to Optimize for Phase III Dose Selection Bret Musser, Merck ; Ghassan Fayad, Merck ; Yue Shentu, Bausch and Lomb ; James A. Bolognese, Cytel ; Nitin Patel, Cytel ; Jaydeep Bhattacharyya, Cytel
2:25 PM WITHDRAWN: Optimizing a Clinical Trial Within the Context of an Adaptive Clinical Drug Development Plan — Brenda Gaydos, Eli Lilly and Company
2:45 PM Phase 2B Strategies and Optimization of Drug Development Programs Zoran Antonijevic, Cytel
3:05 PM Designing Phase III Trials to Optimize the Value of a Portfolio Nitin Patel, Cytel ; Suresh Ankolekar, Maastricht School of Management
3:25 PM Discussant: Olga V. Marchenko, Quintiles
3:45 PM Floor Discussion

2014 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Professional Development program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.